Clinical Trial Update: Immune Modulation From Trichuris Suis

View source ↗

Summary

A completed clinical trial evaluated Trichuris suis ova as an immune-modulating therapy for Crohn's disease and ulcerative colitis. Intestinal helminthiasis is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Intestinal Helminthiasis
• Ulcerative Colitis

Drugs mentioned

• Trichuris suis ova (TSO) (Trichuris suis ova)

Snippet

Sponsor: University of Aarhus | Conditions: Crohn Disease, Ulcerative Colitis | Status: COMPLETED